CyberSecBulletin
CVE-2023-33363NVD status: Modified

Biostar 2: Improper Authentication

CVE-2023-33363 is a high-severity improper authentication vulnerability in Biostar 2 from Supremainc, with a CVSS 3.1 base score of 7.5 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, without any action from a user. The record lists version 2.9.1 as the first without the flaw, so updating Biostar 2 to that release or later removes the exposure. There is no confirmed exploitation so far. EPSS estimates a 0.56% chance of exploitation within 30 days, which is low compared with other CVEs.

Next patch cycle

High severity with no evidence of exploitation so far.

What to do

  1. Update Biostar 2 to 2.9.1 or a later version.
  2. Read the advisory on kb.supremainc.com for workarounds and exact fixed builds.
  3. Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.

Affected products and versions

VendorProductAffected versionsFixed in
SupremaincBiostar 2before 2.9.12.9.1

Version data comes from NVD's product matching. Confirm against the vendor advisory before deciding you are unaffected.

How the severity score breaks down

Attack vector
NetworkCan be exploited remotely over a network, including the internet.
Attack complexity
LowNo special conditions are needed; the attack works reliably.
Privileges required
NoneNo account or login is needed.
User interaction
NoneNo action by a victim is required.
Scope
UnchangedImpact stays within the vulnerable component.
Confidentiality
NoneNo data is disclosed.
Integrity
HighData or code can be modified at will.
Availability
NoneAvailability is not affected.

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N. Scored by NVD.

Official description

An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.

Source: the CVE record as published by its numbering authority, via NVD and CVE.org.

The underlying weakness: Improper Authentication

When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct.

How developers prevent this class of flaw

  • Use an authentication framework or library such as the OWASP ESAPI Authentication feature.

More Improper Authentication vulnerabilities (CWE-287)

Timeline

  1. CVE record published.
  2. CISA published its SSVC assessment (exploitation: none, automatable: yes, technical impact: partial).
  3. Record last changed materially (score, affected products, status or references).

References

Third-party and government advisories

Other vulnerabilities in Biostar 2

All Biostar 2 vulnerabilities

Recent Improper Authentication vulnerabilities

Spotted an error? Tell us.